Literature DB >> 8622394

Human parvovirus B19 infection associated with acute hepatitis.

Y Yoto1, T Kudoh, K Haseyama, N Suzuki, S Chiba.   

Abstract

BACKGROUND: Human parvovirus (HPV) B19 infection produces a range of clinical manifestations including erythema infectiosum in children. Here we describe seven children who had acute hepatitis with HPV B19 infection.
METHODS: Hepatic dysfunction was noted in three children referred to our hospital during the course of erythema infectiosum caused by HPV B19 infection diagnosed by ELISA and PCR. The role of HPV B19 in the pathogenesis of hepatic involvement was investigated retrospectively by PCR assay of stored serum samples from 773 patients admitted to our hospital.
FINDINGS: 15 patients admitted to our hospital from January, 1991, to June, 1992, were HPV B19 DNA positive, of whom four had acute hepatitis of unknown origin. These four patients were aged between 7 months and 5 years. Of the seven patients, infection with hepatitis A, B, or C viruses or Epstein-Barr virus was ruled out in six by virological examinations.
INTERPRETATION: Epidemiological evidence suggests that HPV B19 can be the cause of acute hepatitis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8622394     DOI: 10.1016/s0140-6736(96)91348-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  27 in total

1.  Acute fulminant hepatic failure associated with parvovirus B19 infection in an immunocompetent adult.

Authors:  Robert J Huang; Brandon C Varr; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2012-03-07       Impact factor: 3.199

2.  Chronic hepatitis caused by persistent parvovirus B19 infection.

Authors:  Trine H Mogensen; Jens Magnus B Jensen; Stephen Hamilton-Dutoit; Carsten S Larsen
Journal:  BMC Infect Dis       Date:  2010-08-20       Impact factor: 3.090

3.  Analysis of nucleotide sequences of human parvovirus B19 genome reveals two different modes of evolution, a gradual alteration and a sudden replacement: a retrospective study in Sapporo, Japan, from 1980 to 2008.

Authors:  Masashi Suzuki; Yuko Yoto; Aki Ishikawa; Hiroyuki Tsutsumi
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

4.  Detection of parvovirus B19 in skin biopsy, serum, and bone marrow of a patient with fever, rash, and polyarthritis followed by pneumonia, pericardial effusion, and hepatitis.

Authors:  S Nikkari; H Lappalainen; R Saario; K Lammintausta; P Kotilainen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-12       Impact factor: 3.267

5.  Down-regulation of inwardly rectifying Kir2.1 K+ channels by human parvovirus B19 capsid protein VP1.

Authors:  Musaab Ahmed; Bernat Elvira; Ahmad Almilaji; C-Thomas Bock; Reinhard Kandolf; Florian Lang
Journal:  J Membr Biol       Date:  2014-12-09       Impact factor: 1.843

6.  Characterization of erythrovirus B19 genomes isolated in liver tissues from patients with fulminant hepatitis and biliary atresia who underwent liver transplantation.

Authors:  Kenji Abe; Tetsuya Kiuchi; Koichi Tanaka; Yoshihiro Edamoto; Naoto Aiba; Tetsutaro Sata
Journal:  Int J Med Sci       Date:  2007-04-05       Impact factor: 3.738

7.  Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q.

Authors:  Kristina von Kietzell; Tanja Pozzuto; Regine Heilbronn; Tobias Grössl; Henry Fechner; Stefan Weger
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

8.  Parvovirus B19 genotype specific amino acid substitution in NS1 reduces the protein's cytotoxicity in culture.

Authors:  Violetta Kivovich; Leona Gilbert; Matti Vuento; Stanley J Naides
Journal:  Int J Med Sci       Date:  2010-05-25       Impact factor: 3.738

9.  Quantification of parvovirus B19 DNA using COBAS AmpliPrep automated sample preparation and LightCycler real-time PCR.

Authors:  Stefan Schorling; Gunnar Schalasta; Gisela Enders; Michael Zauke
Journal:  J Mol Diagn       Date:  2004-02       Impact factor: 5.568

10.  Parvovirus B19 induced hepatic failure in an adult requiring liver transplantation.

Authors:  Darin S Krygier; Urs P Steinbrecher; Martin Petric; Siegfried R Erb; Stephen W Chung; Charles H Scudamore; Andrzej K Buczkowski; Eric M Yoshida
Journal:  World J Gastroenterol       Date:  2009-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.